English | Español
Ruth de Jauregui | May 21, 2017

GlaxoSmithKline reviewing latest studies of treatment for COPD patients
Ruth de Jauregui | May 21, 2017

AstraZeneca reports positive results in trial using Imfinzi in Stage III non-small cell lung cancer cases
Ruth de Jauregui | May 21, 2017

NIH study links racial segregation, high blood pressure
Ruth de Jauregui | May 21, 2017

Lilly says studies show galcanezumab can reduce migraine episodes
Ruth de Jauregui | May 21, 2017

American Academy of Family Physicians mails out latest immunization information
Cheyenne Dickerson | May 21, 2017

Arena Pharmaceuticals preparing to present ralinepag drug Phase 1 results

Robert Hadley | May 21, 2017

Three years of outcomes show Entyvio tames irritable bowel disease 
Ruth de Jauregui | May 21, 2017

Novartis Foundation announces new initiative on World Hypertension Day

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

Baylor College of Medicine partners with Site Tx on immune-targeted drug discovery